Spots Global Cancer Trial Database for Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Official Title: Prospective Randomized Study on Therapeutic Gain Achieved By Addition of Chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma
Study ID: NCT00563927
Study Description
Brief Summary: To test the therapeutic ratio of additional chemotheray on advanced nasopharyngeal carcinoma.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pamela Youde Nethersole Eastern Hospital, Hong Kong, , China
Queen Elizabeth Hospital, Hong Kong, , China
Queen Mary Hospital, Hong Kong, , China
Tuen Mun Hospital, Hong Kong, , China
Contact Details
Name: Wai Hon LAU, Dr
Affiliation: Department of Clinical Oncology, Queen Elizabeth Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
